Science
Jemincare group has completed the Phase I clinical trial of its anti-SARS-CoV-2 neutralizing antibody JMB2002 – PR Newswire India
/PRNewswire/ — Recently, Jemincare group has declared that it has completed phase I clinical trial of self-developed novel coronavirus…
The clinical trial of JMB2002 was stated in January 2021. A single-center, randomized, double-blind, placebo-controlled, single-dose escalation phase I trial was designed to evaluate JMB2002’s tolerability, safety, pharmacokinetic characteristics and immunogenicity…
-
General22 hours agoQueensland government strikes new deal with Bravus to defer royalties, expand Carmichael coal mine
-
General24 hours agoVulnerable youth non-for-profit Allambi Care agrees to end ‘unacceptable’ housing scheme
-
Noosa News21 hours agoFamily’s heartbreak after Trevor Doyle found dead in park in Logan
-
General20 hours agoTwo men involved in fatal helicopter accident charged over stealing crocodile eggs from Kakadu National Park